Introduction and WHO perspective on the global burden of musculoskeletal conditions

Rheumatology (Oxford). 2002 Apr:41 Supp 1:1-2.

Authors

J Y Reginster¹, N G Khaltaev

Affiliation

¹ WHO Collaborating Centre for Public Health Aspects of Rheumatic Disorders, University of Liège, B-4020 Liège, Belgium.

PMID: 12173275

No abstract available

MeSH terms

Anti-Inflammatory Agents, Non-Steroidal / adverse effects
Anti-Inflammatory Agents, Non-Steroidal / economics
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
Arthritis, Rheumatoid / drug therapy
Arthritis, Rheumatoid / epidemiology*
Cost of Illness*
Cyclooxygenase Inhibitors / therapeutic use
Humans
Osteoarthritis / drug therapy
Osteoarthritis / epidemiology*
Pain / drug therapy
Quality of Life
Severity of Illness Index
World Health Organization

Substances

Anti-Inflammatory Agents, Non-Steroidal
Cyclooxygenase Inhibitors